RhumbLine Advisers’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $460K | Buy |
|
|||||
|
2025
Q1 | $379K | Sell |
|
|||||
|
2024
Q4 | $272K | Buy |
|
|||||
|
2024
Q3 | $350K | Sell |
|
|||||
|
2024
Q2 | $646K | Buy |
|
|||||
|
2024
Q1 | $388K | Buy |
|
|||||
|
2023
Q4 | $231K | Buy |
|
|||||
|
2023
Q3 | $139K | Sell |
|
|||||
|
2023
Q2 | $159K | Buy |
|
|||||
|
2023
Q1 | $206K | Buy |
|
|||||
|
2022
Q4 | $332K | Buy |
|
|||||
|
2022
Q3 | $545K | Buy |
|
|||||
|
2022
Q2 | $337K | Buy |
|
|||||
|
2022
Q1 | $579K | Sell |
|
|||||
|
2021
Q4 | $941K | Sell |
|
|||||
|
2021
Q3 | $1.12M | Buy |
|
|||||
|
2021
Q2 | $1.56M | Sell |
|
|||||
|
2021
Q1 | $1.7M | Sell |
|
|||||
|
2020
Q4 | $2.44M | Buy |
|
|||||
|
2020
Q3 | $1.7M | Sell |
|
|||||
|
2020
Q2 | $1.98M | Buy |
|
|||||
|
2020
Q1 | $1.38M | Buy |
|
|||||
|
2019
Q4 | $2.66M | Buy |
|
|||||
|
2019
Q3 | $1.86M | Buy |
|
|||||
|
2019
Q2 | $1.85M | Buy |
|
|||||
|
2019
Q1 | $2.17M | Sell |
|
|||||
|
2018
Q4 | $2.32M | Buy |
|
|||||
|
2018
Q3 | $1.86M | Sell |
|
|||||
|
2018
Q2 | $2.31M | Buy |
|
|||||
|
2018
Q1 | $1.36M | Buy |
|
|||||
|
2017
Q4 | $777K | Sell |
|
|||||
|
2017
Q3 | $826K | Buy |
|
|||||
|
2017
Q2 | $701K | Buy |
|
|||||
|
2017
Q1 | $666K | Buy |
|
|||||
|
2016
Q4 | $453K | Sell |
|
|||||
|
2016
Q3 | $611K | Buy |
|
|||||
|
2016
Q2 | $635K | Buy |
|
|||||
|
2016
Q1 | $553K | Buy |
|
|||||
|
2015
Q4 | $776K | Buy |
|
|||||
|
2015
Q3 | $642K | Buy |
|
|||||
|
2015
Q2 | $673K | Buy |
|
|||||
|
2015
Q1 | $311K | Buy |
|
|||||
|
2014
Q4 | $165K | Buy |
|
|||||
|
2014
Q3 | $132K | Buy |
|
|||||
|
2014
Q2 | $172K | Buy |
|